Drupal.behaviors.print = function(context) {window.print();window.close();}>
Stanford Scientists Using Phosphoprotein Profiling to Predict Oncogene Addiction, Drug Response
October 14, 2011
Stanford Scientists Using Phosphoprotein Profiling to Predict Oncogene Addiction, Drug Response
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
Integrated Diagnostics Forms New Division to House Imaging Business as PCC Development Continues
June 15, 2012 / ProteoMonitor
Integrated Diagnostics Taking Aim at In Vivo Imaging, Therapeutics Markets with New PCC Reagents
October 28, 2011 / ProteoMonitor
GenomeWeb Feature: The Unsteady March of Cancer Protein Biomarkers into the Clinic
May 10, 2013 / ProteoMonitor
Theranostics Health to Launch HER Signaling Assay, Marking Firm's First Commercial Test Release
May 3, 2013 / ProteoMonitor
Caprion Leading $21M Clinical Biomarker and Personalized Medicine Development Project
February 22, 2013 / ProteoMonitor